Celloid
PrivateLast Round
Series A
Mar 12, 2026
Est. Valuation
$26.32M
Total Funding Raised
$6.77M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Celloid is a biotechnology company that develops and supplies three-dimensional (3D) cell culture automation systems and solutions for organoids and spheroids.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celloid Comparables
Compare Celloid with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CelVivo | 80% | |
| AIM Biotech | 79% | |
| mo:re | 78% |
Celloid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 12, 2026 | ||||
| VC Round | Jan 31, 2024 | ||||
| Seed | Jun 1, 2022 |
Celloid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| POSTECH Holdings Co., Ltd. | VC Round, Seed |
| FuturePlay | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
$7M round completed
- Jan 31, 2024
$1.8M round led by POSTECH Holdings and FuturePlay.
Celloid Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Celloid's valuation, stock price, and market status.
Is Celloid a public or private company?
Celloid is a private company.
What is the current stock price of Celloid?
Celloid is a private company with no public stock price. No recent secondary market data is available.
How much is Celloid worth (valuation)?
Celloid's valuation is estimated at $26.3M based on funding round data.
Can I buy Celloid stock?
Celloid shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Celloid's last funding round?
Celloid's most recent funding round was Series A on March 12, 2026.
Who are the main investors in Celloid?
Key investors in Celloid include POSTECH Holdings Co., Ltd., FuturePlay.
Will Celloid IPO soon?
No public IPO plans have been announced for Celloid.
How can I track Celloid secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Celloid's secondary market activity and sign up for updates.